TMDX
TransMedics Group, Inc. · Healthcare
Director David Weill sold $524K of TransMedics Group, Inc.
Sold$524,294
$146.82Price
3,571Shares
−23%Stake
What TMDX did after the filing
- The stock from Fri, Mar 6 close, $129.61
- −12.7%
- S&P 500, same days
- +5.4%
Measured over 30 trading days, to the Apr 20 close.
Traded Wed, Mar 4. Filed Fri, Mar 6, 1:09 PM ET, during the session. Returns use the Mar 6 close and the Apr 20 close. Not investment advice.